Tseng, L. A., Engelke, U. F. H., Huigen, M. C. D. G., Kluijtmans, L. A. J., Haaxma, C. A., Koolen, D. A., … Coene, K. L. M. (2022). Targeting the Diagnosis in an Adolescent with Epilepsy and Intellectual Disability through Next-Generation Metabolic Screening. Clin Chem, 68(5), 732–735. https://doi.org/10.1093/clinchem/hvab276

Tseng, Laura A., Udo F. H. Engelke, Marleen C. D. G. Huigen, Leo A. J. Kluijtmans, Charlotte A. Haaxma, David A. Koolen, Levinus A. Bok, et al. “Targeting the Diagnosis in an Adolescent with Epilepsy and Intellectual Disability through Next-Generation Metabolic Screening.” Clin Chem 68, no. 5 (May 18, 2022): 732–35. https://doi.org/10.1093/clinchem/hvab276.

Tseng LA, Engelke UFH, Huigen MCDG, Kluijtmans LAJ, Haaxma CA, Koolen DA, et al. Targeting the Diagnosis in an Adolescent with Epilepsy and Intellectual Disability through Next-Generation Metabolic Screening. Clin Chem. 2022 May 18;68(5):732–5.

Tseng, Laura A., et al. “Targeting the Diagnosis in an Adolescent with Epilepsy and Intellectual Disability through Next-Generation Metabolic Screening.” Clin Chem, vol. 68, no. 5, May 2022, pp. 732–35. Pubmed, doi:10.1093/clinchem/hvab276.

Tseng LA, Engelke UFH, Huigen MCDG, Kluijtmans LAJ, Haaxma CA, Koolen DA, Bok LA, Wright JN, Gospe SM, Janssen MCH, van Karnebeek CDM, Coene KLM. Targeting the Diagnosis in an Adolescent with Epilepsy and Intellectual Disability through Next-Generation Metabolic Screening. Clin Chem. 2022 May 18;68(5):732–735.